Organon Pharma Indonesia Tbk. vs Unggul Indah Cahaya Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Unggul Indah Cahaya Tbk. trades at Rp15,050 (market cap 5.75T, 54.9K 24h volume). The key difference: Unggul Indah Cahaya Tbk. is far larger — about 55.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | UNIC | |
|---|---|---|
Market Cap | 104.4B | 5.75T |
Volume | — | 54.9K |
Lot | — | 549 |
Turnover | — | 822.11M |
Average Price | — | 14,974.73 |
Value | — | 822.11M |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Unggul Indah Corporation Tbk (The Company), formerly PT Unggul Indah Corporation Tbk manufactures Alkylbenzene (AB) raw material in detergent production was established in 1983. The company began its commercial operations in November 1985 and became a publicly listed company in November 1989. Currently, its stocks are traded in Jakarta and Surabaya Stock Exchange. The main customers of the Company represent large and prominent detergent manufacturer, such as Wings, Unilever, Kao and Dino.
Read more on UNIC →